These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
613 related articles for article (PubMed ID: 26498144)
1. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators. Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144 [TBL] [Abstract][Full Text] [Related]
2. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related]
3. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1). Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor. Wang K; Liang Q; Wei L; Zhang W; Zhu P Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267 [TBL] [Abstract][Full Text] [Related]
7. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6. Zhu H; Wang G; Zhou X; Song X; Gao H; Ma C; Chang H; Li H; Liu FF; Lu J; Ma J Biomed Pharmacother; 2016 Oct; 83():792-797. PubMed ID: 27490780 [TBL] [Abstract][Full Text] [Related]
8. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma. Dong Y; Zou J; Su S; Huang H; Deng Y; Wang B; Li W Mol Med Rep; 2015 Jul; 12(1):1016-22. PubMed ID: 25816091 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356 [TBL] [Abstract][Full Text] [Related]
11. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
15. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257 [TBL] [Abstract][Full Text] [Related]
17. microRNA-200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6. Xiao F; Zhang W; Zhou L; Xie H; Xing C; Ding S; Chen K; Zheng S Oncol Rep; 2013 Nov; 30(5):2203-10. PubMed ID: 24009066 [TBL] [Abstract][Full Text] [Related]
18. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT Carcinogenesis; 2012 May; 33(5):1113-20. PubMed ID: 22362728 [TBL] [Abstract][Full Text] [Related]
19. MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2. Fang ZQ; Li MC; Zhang YQ; Liu XG J Cell Biochem; 2018 Nov; 119(10):8317-8324. PubMed ID: 29932246 [TBL] [Abstract][Full Text] [Related]
20. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]